[3] Initial treatment of pernicious anemia typically consists of 1,000 mcg intramuscularly daily for one week, then weekly for four weeks, transitioning to 1,000 mcg monthly for life
However, no peer-reviewed human clinical trials have been published to date
Innovations in regenerative medicine, tissue engineering, and personalized medicine are on the horizon, driven by ongoing research and development
While debates persist about its classification, whats undeniable is its discoverys profound impact in 2017
Dr.Terranas knowledge in his specialty in addition to professionalism, patience and bedside manner is highly recommended